Cargando…

Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice

OBJECTIVE: Almost half of HIV-positive people on antiretroviral therapy have demonstrable mild neurocognitive impairment (HIV-NCI), even when virologically suppressed. Intranasal insulin therapy improves cognition in Alzheimer's disease and diabetes. Here we tested intranasal insulin therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Boe-Hyun, Kelschenbach, Jennifer, Borjabad, Alejandra, Hadas, Eran, He, Hongxia, Potash, Mary Jane, Nedelcovych, Michael T., Rais, Rana, Haughey, Norman J., McArthur, Justin C., Slusher, Barbara S., Volsky, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457131/ https://www.ncbi.nlm.nih.gov/pubmed/30946151 http://dx.doi.org/10.1097/QAD.0000000000002150

Ejemplares similares

EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment
por: Gu, Chao-Jiang, et al.
Publicado: (2018)

Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI
por: Murphy, Aniella J., et al.
Publicado: (2022)

Protocol for optimizing production and quality control of infective EcoHIV virions
por: Alfar, Hammodah R., et al.
Publicado: (2023)

Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
por: Bell, Benjamin J., et al.
Publicado: (2022)

CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice
por: Kim, Boe-Hyun, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model
por: Omeragic, Amila, et al.
Publicado: (2019)

Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses
por: Dong, Baojun, et al.
Publicado: (2020)

Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats
por: McLaurin, Kristen A., et al.
Publicado: (2022)

Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis
por: Borjabad, Alejandra, et al.
Publicado: (2012)

Efficient Expression of HIV in Immunocompetent Mouse Brain Reveals a Novel Nonneurotoxic Viral Function in Hippocampal Synaptodendritic Injury and Memory Impairment
por: Kelschenbach, Jennifer, et al.
Publicado: (2019)

Enhanced Human Immunodeficiency Virus Type 1 Expression and Neuropathogenesis in Knockout Mice Lacking Type I Interferon Responses
por: He, Hongxia, et al.
Publicado: (2014)

Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
por: Borjabad, Alejandra, et al.
Publicado: (2011)

Implication of the Autophagy-Related Protein Beclin1 in the Regulation of EcoHIV Replication and Inflammatory Responses
por: Rodriguez, Myosotys, et al.
Publicado: (2023)

Response to ‘Remarks on the article of Hadas et al.: Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus’
por: Potash, Mary Jane, et al.
Publicado: (2014)

Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
por: Zhu, Xiaolei, et al.
Publicado: (2022)

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
por: Tomusange, Khamis, et al.
Publicado: (2016)

Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus
por: Hadas, Eran, et al.
Publicado: (2013)

HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis
por: Nitkiewicz, Jadwiga, et al.
Publicado: (2017)

Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
por: Potter, Michelle C., et al.
Publicado: (2013)

Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders
por: Merali, Salim, et al.
Publicado: (2014)

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration
por: Rais, Rana, et al.
Publicado: (2015)

Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound
por: Yoo, Seung-Wan, et al.
Publicado: (2023)

HIV and Neurocognitive Dysfunction
por: Spudich, Serena
Publicado: (2013)

NEUROCOGNITIVE IMPAIRMENTS IN HIV INFECTION
por: Edwin, Tony, et al.
Publicado: (1999)

HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013)

HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014)

Neuroimaging of HIV-associated neurocognitive disorders
por: Haziot, Michel Elyas Jung, et al.
Publicado: (2015)

Intranasal Insulin Administration to Prevent Delayed Neurocognitive Recovery and Postoperative Neurocognitive Disorder: A Narrative Review
por: Badenes, Rafael, et al.
Publicado: (2021)

Neurocognitive functioning in acute or early HIV infection
por: Moore, David J., et al.
Publicado: (2010)

Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
por: Davies, Nicholas W.S., et al.
Publicado: (2010)

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders
por: Woods, Steven Paul, et al.
Publicado: (2009)

Adjuvant therapies for HIV-associated neurocognitive disorders
por: McGuire, Jennifer L, et al.
Publicado: (2014)

Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders
por: Allen, Charles N. S., et al.
Publicado: (2022)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection
por: Asaduzzaman, Md, et al.
Publicado: (2023)

Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder
por: Reddy, Pichili Vijaya Bhaskar, et al.
Publicado: (2012)

HIV-Associated Neurocognitive Disorders: The Relationship of HIV Infection with Physical and Social Comorbidities
por: Tedaldi, Ellen M., et al.
Publicado: (2015)

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
por: Mediouni, Sonia, et al.
Publicado: (2015)

Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
por: Li, Hailong, et al.
Publicado: (2021)

Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infection
por: Li, Jinliang, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_7sugfgpu00eqmguik8dcrnie50